Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.

Berenson JR, Yellin O, Kazamel T, Hilger JD, Chen CS, Cartmell A, Woliver T, Flam M, Bravin E, Nassir Y, Vescio R, Swift RA.

Leukemia. 2012 Jul;26(7):1675-80. doi: 10.1038/leu.2012.51. Epub 2012 Feb 22.

PMID:
22354206
2.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock J, Myerson R, Anne R, Rosenthal SA, Willett C.

J Clin Oncol. 2010 Dec 1;28(34):5061-6. doi: 10.1200/JCO.2010.29.1351. Epub 2010 Oct 18.

3.

Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.

Berenson JR, Yellin O, Woytowitz D, Flam MS, Cartmell A, Patel R, Duvivier H, Nassir Y, Eades B, Abaya CD, Hilger J, Swift RA.

Eur J Haematol. 2009 Jun;82(6):433-9. doi: 10.1111/j.1600-0609.2009.01244.x. Epub 2009 Feb 17.

PMID:
19226361
4.

Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.

Nagourney RA, Flam M, Link J, Hager S, Blitzer J, Lyons W, Sommers BL, Evans S.

Clin Breast Cancer. 2008 Oct;8(5):432-5. doi: 10.3816/CBC.2008.n.052.

PMID:
18952557
5.

Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss.

Berenson JR, Yellin O, Boccia RV, Flam M, Wong SF, Batuman O, Moezi MM, Woytowitz D, Duvivier H, Nassir Y, Swift RA.

Clin Cancer Res. 2008 Oct 1;14(19):6289-95. doi: 10.1158/1078-0432.CCR-08-0666.

6.

Basal cell carcinoma metastatic to cervical lymph nodes and lungs.

Boswell JS, Flam MS, Tashjian DN, Tschang TP.

Dermatol Online J. 2006 Oct 31;12(6):9.

PMID:
17083889
7.

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study.

Berenson JR, Boccia R, Siegel D, Bozdech M, Bessudo A, Stadtmauer E, Talisman Pomeroy J, Steis R, Flam M, Lutzky J, Jilani S, Volk J, Wong SF, Moss R, Patel R, Ferretti D, Russell K, Louie R, Yeh HS, Swift RA.

Br J Haematol. 2006 Oct;135(2):174-83. Erratum in: Br J Haematol. 2007 Jan;136(1):173-4.

PMID:
17010047
8.
10.
11.

Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.

John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H, Paris K.

Cancer J Sci Am. 1996 Jul-Aug;2(4):205-11.

PMID:
9166533
12.

Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15.

John M, Flam M, Caplan R, Rotman M, Quivey J, Steinfeld A, Russell A.

Gynecol Oncol. 1996 May;61(2):221-6.

PMID:
8626137
13.

Ten-year results of chemoradiation for anal cancer: focus on late morbidity.

John M, Flam M, Palma N.

Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):65-9.

PMID:
12118566
14.

Long-term palliation of pulmonary artery sarcoma by radical excision and adjuvant therapy.

Head HD, Flam MS, John MJ, Lipnik SS, Slater DL, Stewart RD.

Ann Thorac Surg. 1992 Feb;53(2):332-4.

PMID:
1731680
15.

Improved food intake and reduced nausea and vomiting in patients given a restricted diet while receiving cisplatin chemotherapy.

Menashian L, Flam M, Douglas-Paxton D, Raymond J.

J Am Diet Assoc. 1992 Jan;92(1):58-61.

PMID:
1728624
16.

Curative treatment approaches for esophageal cancer.

John M, Flam M.

Front Radiat Ther Oncol. 1992;26:83-94. No abstract available.

PMID:
1387381
17.

Angiosarcoma in postsurgical lymphedema. An unusual occurrence in a man.

Chen KT, Bauer V, Flam MS.

Am J Dermatopathol. 1991 Oct;13(5):488-92.

PMID:
1951986
18.

Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.

Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MS.

Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):709-14.

PMID:
1651306
19.

Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group.

Carlson RW, Doroshow JH, Odujinrin OO, Flam MS, Malec M, Lamborn KR.

Invest New Drugs. 1990 Nov;8(4):387-9. No abstract available.

PMID:
2150672
20.

Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.

John M, Flam M, Sikic B, Rotman M, Cooper J, Malec M, Hannigan J, Phillips T.

Gynecol Oncol. 1990 Apr;37(1):1-5.

PMID:
2108909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk